{
    "nct_id": "NCT06510699",
    "official_title": "Randomized Clinical Trial to Evaluate the Use of Genotype-based Dosing of Voriconazole in Patients With Haematological Malignancy",
    "inclusion_criteria": "* Age â‰¥ 2 years.\n* Written informed consent obtained.\n* Decision to prescribe voriconazole.\n* Diagnosed with haematological malignancy or disorder.\n* Admitted to a trial site, or sufficient outpatient follow-up appointments are feasible\nHealthy volunteers allowed\nMust have minimum age of 2 Years",
    "exclusion_criteria": "* Post-allogeneic haematopoietic stem cell transplant (HCT) patient, without access to pre HCT DNA\n* Death is likely imminent within 7 days.\n* Previously randomised to this trial",
    "miscellaneous_criteria": ""
}